[{"address1": "217 Queen Street West", "address2": "Suite 301", "city": "Toronto", "state": "ON", "zip": "M5V 0R2", "country": "Canada", "website": "https://awaknlifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Awakn Life Sciences Corp., a biotechnology company, engages in the research, development, operation, and delivery of psychedelic therapeutics to treat addiction and other mental health conditions in North America and Europe. It develops AWKN-001, a novel medication-assisted treatments (MAT) consisting of racemic ketamine, delivered intravenously, and manualized relapse prevention cognitive behavioural therapy (CBT) which is in phase 3 trials to treat severe Alcohol Use Disorder (AUD); AWKN-002, a novel MAT consisting of a patent pending proprietary S\u0096ketamine oral thin film, and manualized relapse prevention CBT to treat AUD; and MDMA/Zydis, an investigational medicinal product entactogen that acts as a releaser and reuptake inhibitor of serotonin, norepinephrine, and dopamine. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. George  Scorsis", "age": 46, "title": "Co-founder & Chairman of the Board", "yearBorn": 1977, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Anthony  Tennyson", "title": "Co-founder, President, CEO & Director", "fiscalYear": 2023, "totalPay": 175743, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathan James Held C.A., CPA, CA", "age": 37, "title": "Interim CFO, Chief Business Officer & Secretary", "yearBorn": 1986, "fiscalYear": 2023, "totalPay": 109842, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. David John Nutt DM, FMedSci, FRCP, FRCPsych, FSB, Ph.D.", "title": "Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.1275, "open": 0.11, "dayLow": 0.11, "dayHigh": 0.11, "regularMarketPreviousClose": 0.1275, "regularMarketOpen": 0.11, "regularMarketDayLow": 0.11, "regularMarketDayHigh": 0.11, "forwardPE": -0.45833334, "volume": 7455, "regularMarketVolume": 7455, "averageVolume": 9656, "averageVolume10days": 2879, "averageDailyVolume10Day": 2879, "marketCap": 4347178, "fiftyTwoWeekLow": 0.0422, "fiftyTwoWeekHigh": 0.26, "priceToSalesTrailing12Months": 49.75425, "fiftyDayAverage": 0.1225372, "twoHundredDayAverage": 0.1267635, "currency": "USD", "enterpriseValue": 3068759, "floatShares": 26060344, "sharesOutstanding": 39519800, "heldPercentInsiders": 0.08449, "heldPercentInstitutions": 0.062280003, "impliedSharesOutstanding": 44058400, "bookValue": -0.048, "lastFiscalYearEnd": 1706659200, "nextFiscalYearEnd": 1738281600, "mostRecentQuarter": 1706659200, "earningsQuarterlyGrowth": -0.781, "netIncomeToCommon": -898992, "trailingEps": -0.09, "forwardEps": -0.24, "enterpriseToRevenue": 35.123, "enterpriseToEbitda": -0.785, "52WeekChange": -0.46859902, "SandP52WeekChange": 0.23485482, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "AWKNF", "underlyingSymbol": "AWKNF", "shortName": "AWAKN LIFE SCIENCES CORP", "longName": "Awakn Life Sciences Corp.", "firstTradeDateEpochUtc": 1627997400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "595fd0b1-2e29-3fed-b382-0b786bf6dbf2", "messageBoardId": "finmb_673256170", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.11, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 407301, "totalCashPerShare": 0.013, "ebitda": -3908204, "quickRatio": 0.206, "currentRatio": 0.239, "totalRevenue": 87373, "revenuePerShare": 0.003, "returnOnAssets": -0.99415, "freeCashflow": -1344285, "operatingCashflow": -2381416, "grossMargins": 1.0, "operatingMargins": -38.61037, "financialCurrency": "CAD", "trailingPegRatio": null, "__fetch_time": "2024-06-03"}]